DB289 ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
65原発性免疫不全症候群2

65. 原発性免疫不全症候群


臨床試験数 : 500 薬物数 : 614 - (DrugBank : 119) / 標的遺伝子数 : 92 - 標的パスウェイ数 : 217
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00803933
(ClinicalTrials.gov)
February 20034/12/2008Trial of DB289 for the Treatment of Stage I African TrypanosomiasisPhase II b Trial of DB289 for the Treatment of Stage I African TrypanosomiasisAfrican TrypanosomiasisDrug: DB289;Drug: PentamidineImmtech Pharmaceuticals, IncBill and Melinda Gates FoundationCompleted15 Years50 YearsBoth111Phase 2Congo
2NCT00802594
(ClinicalTrials.gov)
August 20013/12/2008A Trial of DB289 for the Treatment of Stage I African TrypanosomiasisPhase II A Trial of DB289 for the Treatment of Stage I African TrypanosomiasisTrypanosomiasis, AfricanDrug: DB289Immtech Pharmaceuticals, IncBill and Melinda Gates FoundationCompleted16 YearsN/ABoth30Phase 2Angola;Congo